Alec E Vaezi et al.26reported that PCYT1A (phosphate cytidylyltransferase 1A, choline) has biomarker value in patients with lung cancer and that high PCYT1A expression implies longer survival, but there is a lack of studies in hepatocellular carcinoma. This evidence concerns the gene PCYT1A and hepatocellular carcinoma.